SK282745B6 - Farmaceutická kompozícia obsahujúca cyklosporínový derivát - Google Patents

Farmaceutická kompozícia obsahujúca cyklosporínový derivát Download PDF

Info

Publication number
SK282745B6
SK282745B6 SK1272-94A SK127294A SK282745B6 SK 282745 B6 SK282745 B6 SK 282745B6 SK 127294 A SK127294 A SK 127294A SK 282745 B6 SK282745 B6 SK 282745B6
Authority
SK
Slovakia
Prior art keywords
weight
pharmaceutical composition
carrier
constitutes
composition according
Prior art date
Application number
SK1272-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK127294A3 (en
Inventor
Friedrich Richter
Armin Meinzer
Jacky Francis Vonderscher
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK127294A3 publication Critical patent/SK127294A3/sk
Publication of SK282745B6 publication Critical patent/SK282745B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SK1272-94A 1992-04-22 1993-04-20 Farmaceutická kompozícia obsahujúca cyklosporínový derivát SK282745B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929208712A GB9208712D0 (en) 1992-04-22 1992-04-22 Pharmaceutical compositions containing cyclosporin derivates
PCT/EP1993/000955 WO1993020833A1 (en) 1992-04-22 1993-04-20 Pharmaceutical composition containing cyclosporin derivative

Publications (2)

Publication Number Publication Date
SK127294A3 SK127294A3 (en) 1995-04-12
SK282745B6 true SK282745B6 (sk) 2002-12-03

Family

ID=10714386

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1272-94A SK282745B6 (sk) 1992-04-22 1993-04-20 Farmaceutická kompozícia obsahujúca cyklosporínový derivát

Country Status (22)

Country Link
EP (1) EP0637248B1 (uk)
JP (1) JP2818298B2 (uk)
KR (2) KR950701227A (uk)
AT (1) ATE219940T1 (uk)
AU (1) AU672793B2 (uk)
CA (1) CA2132740C (uk)
CY (1) CY2399B1 (uk)
CZ (1) CZ287359B6 (uk)
DE (1) DE69332078T2 (uk)
DK (1) DK0637248T3 (uk)
ES (1) ES2179052T3 (uk)
FI (1) FI111130B (uk)
GB (1) GB9208712D0 (uk)
HU (1) HU218279B (uk)
NO (1) NO315075B1 (uk)
NZ (1) NZ252681A (uk)
PT (1) PT637248E (uk)
RU (1) RU2126263C1 (uk)
SG (1) SG50692A1 (uk)
SK (1) SK282745B6 (uk)
UA (1) UA34454C2 (uk)
WO (1) WO1993020833A1 (uk)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DK0642332T3 (da) 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
KR970704464A (ko) 1994-11-03 1997-09-06 가이슐러 에리히, 데커 카를-루드빅 간단한 조성 및 높은 생물 유효성을 갖는 경구 투여용의 신규 사이클로스포린 제형 및 이의 제조방법(Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them)
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
NZ502566A (en) * 1997-07-29 2002-03-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation containing a pyranone and a basic amine
CA2294031E (en) * 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
JP2005500314A (ja) 2001-06-21 2005-01-06 ファイザー・プロダクツ・インク コレステロールエステル転送蛋白インヒビターの自己乳化性製剤
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP2204167A1 (en) * 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
DK2451438T3 (da) 2009-07-07 2014-03-10 Boehringer Ingelheim Int Farmaceutisk sammensætning til en hepatitis C-virus-roteaseinhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins

Also Published As

Publication number Publication date
EP0637248B1 (en) 2002-07-03
FI944978A (fi) 1994-10-21
NO315075B1 (no) 2003-07-07
DE69332078T2 (de) 2002-12-19
PT637248E (pt) 2002-11-29
SG50692A1 (en) 1999-05-25
DE69332078D1 (de) 2002-08-08
DK0637248T3 (da) 2002-10-28
ES2179052T3 (es) 2003-01-16
UA34454C2 (uk) 2001-03-15
GB9208712D0 (en) 1992-06-10
HUT71580A (en) 1995-12-28
NO943998D0 (no) 1994-10-21
CA2132740A1 (en) 1993-10-28
AU672793B2 (en) 1996-10-17
FI111130B (fi) 2003-06-13
HU218279B (en) 2000-07-28
NO943998L (no) 1994-10-21
CZ287359B6 (en) 2000-11-15
RU94046413A (ru) 1996-11-10
JP2818298B2 (ja) 1998-10-30
RU2126263C1 (ru) 1999-02-20
EP0637248A1 (en) 1995-02-08
KR100414853B1 (uk) 2004-01-13
CY2399B1 (en) 2004-09-10
HU9403055D0 (en) 1994-12-28
CZ261794A3 (en) 1995-02-15
SK127294A3 (en) 1995-04-12
KR950701227A (ko) 1995-03-23
AU4261193A (en) 1993-11-18
CA2132740C (en) 2008-01-15
NZ252681A (en) 1996-02-27
FI944978A0 (fi) 1994-10-21
WO1993020833A1 (en) 1993-10-28
ATE219940T1 (de) 2002-07-15
JPH07505872A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
SK282745B6 (sk) Farmaceutická kompozícia obsahujúca cyklosporínový derivát
US6420355B2 (en) Pharmaceutical compositions containing cyclosporins
FI109454B (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
US8722664B2 (en) Spontaneously dispersible N-benzoyl staurosporine compositions
EP1109532B1 (en) Oral micro-emulsion composition of silybin
US6262022B1 (en) Pharmaceutical compositions containing cyclosporin as the active agent
AU5810000A (en) Substantially oil-free cyclosporin compositions
SK2482002A3 (en) Pharmaceutical compositions for oral and topical administration
ZA200006597B (en) Microemulsion preconcentrates containing a piperidine substance p antagonist.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100420